Fermenta Biotech Ltd Stock Price Today (NSE: FERMENTA)

Fermenta Biotech Ltd

559.55+7.95 (+1.44%)
Market Closed

Fundamental Score

...

Fermenta Biotech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Fermenta Biotech Ltd share price today is 559.55, up +1.44% on NSE/BSE as of 7 August 2026. Fermenta Biotech Ltd (FERMENTA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of 1.34K (Cr). The 52-week high for FERMENTA share price is 564.50 and the 52-week low is 256.40. At a P/E ratio of 20.04x, FERMENTA is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 17.36% and a debt-to-equity ratio of 0.28.

Fermenta Biotech Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
559.55
Low
341.20
Volume
37.8K
Change
+41.40%

Fermenta Biotech Ltd share price chart: 41.40% return over the past month. 52-week high ₹564.50, 52-week low ₹256.40.

Fermenta Biotech Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
561.65568.00546.35559.5516.61K (Cr)
560.95560.95544.35551.6019.05K (Cr)
553.30564.50541.95551.6526.71K (Cr)
516.20551.25516.20546.7531.08K (Cr)
509.75518.45506.15511.6025.59K (Cr)
470.00507.20461.55501.2570.23K (Cr)
447.00482.70440.55465.5513.81K (Cr)
465.00468.25447.60451.455.83K (Cr)
433.00458.95433.00456.2519.62K (Cr)
428.05449.45428.05444.0022.58K (Cr)

Fermenta Biotech Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
509.75568.00506.15559.55+9.77%
359.95507.20341.20501.25+39.26%
302.75379.70296.85354.90+17.23%
309.50318.05278.40295.20-4.62%
330.00348.90308.00311.40-5.64%
320.10362.00306.30319.05-0.33%
328.90344.00294.80325.35-1.08%
351.00354.50305.00322.30-8.18%
285.00360.00256.40348.00+22.11%
279.40299.00265.00282.65+1.16%
319.95330.00256.50275.65-13.85%
319.90376.00297.00311.95-2.49%

Returns & Performance

Good

Return on Equity (ROE)

17.36%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

20.36%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

15.64%

Average operating profit margin over 5 years

Dividend Yield

0.82%

Annual dividend as % of current share price

Fermenta Biotech Ltd Valuation Check

Excellent

Price to Earnings (P/E)

20.04x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

34.89x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

64.09%

% shares held by company founders/management

Poor

FII Holding

0.02%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-62.93%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-13.06%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

6.94%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

7.89%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

7.89%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.28x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

8.71x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

268.91 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Fermenta Biotech Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of FERMENTA across key market metrics for learning purposes.

Positive Indicators

9 factors identified

Strong Return on Equity (17.36%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (20.36%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (15.64%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 20.04 vs Industry: 34.89)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Conservative Debt Levels (D/E: 0.28)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (8.71x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Cash Generation (₹268.91 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (64.09%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Profit Decline Concern (-62.93%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-13.06%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Limited Institutional Interest (FII+DII: 0.02%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

Fermenta Biotech Ltd vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare Fermenta Biotech Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
44/100
560
₹1337.18
20.0
Average
17.36%
Good
20.36%
Excellent
0.3
Excellent
7.89%
Good
6.94%
Good
0.82%
66.4/100
1991
₹468821.49
37.7
Average
15.95%
Good
20.53%
Excellent
0.1
Excellent
16.75%
Excellent
11.78%
Good
0.82%
56.3/100
8056
₹193163.97
73.6
Average
16.53%
Good
21.96%
Excellent
0.0
Excellent
5.71%
Good
8.67%
Good
0.41%
51.4/100
5123
₹169902.02
77.5
Average
27.43%
Excellent
15.19%
Good
1.8
Average
12.07%
Good
11.80%
Good
0.76%
Cipla Ltd...
CIPLA500087
40.2/100
1473
₹116131.81
30.5
Average
11.60%
Average
15.49%
Good
0.0
Excellent
9.94%
Good
8.01%
Good
0.90%
74.1/100
1078
₹115375.77
21.3
Average
21.25%
Excellent
21.14%
Excellent
0.5
Excellent
18.77%
Excellent
12.45%
Good
0.09%
Lupin Ltd...
LUPIN500257
83.4/100
2415
₹113976.53
20.0
Average
28.68%
Excellent
29.93%
Excellent
0.3
Excellent
37.02%
Excellent
13.02%
Good
0.72%
61.5/100
2470
₹105053.91
52.3
Average
13.12%
Average
13.50%
Average
0.4
Excellent
10.52%
Good
18.10%
Excellent
0.04%
41/100
1148
₹102660.46
25.6
Average
11.22%
Average
13.04%
Average
0.2
Excellent
15.44%
Excellent
12.09%
Good
0.65%
24.6/100
1580
₹90035.87
25.4
Average
10.06%
Average
12.80%
Average
0.2
Excellent
0.80%
Average
6.32%
Good
0.26%
34.1/100
1816
₹84016.75
93.9
Average
18.30%
Good
17.76%
Good
0.5
Excellent
-1.89%
Poor
7.19%
Good
0.13%

Fermenta Biotech Ltd PE Ratio History

Historical price-to-earnings ratio for FERMENTA — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202526.35₹348.0013.2x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Fermenta Biotech Ltd Dividend History

Annual cash dividends paid by FERMENTA — dividend yield 0.82%

Financial YearDividends Paid (₹ Cr)
FY 20253.61 Cr
FY 20243.61 Cr
FY 20234.20 Cr
FY 20227.21 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Fermenta Biotech Ltd Quarterly Performance

Latest quarterly metrics for FERMENTA — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-13.06%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-62.93%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

6.94%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

7.89%

Compounded annual net profit growth over 5 years

Fermenta Biotech Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for FERMENTA — calculated from daily price history

69RSI 14
Neutral — RSI 69

Momentum is balanced — neither overbought nor oversold.

SMA 50
368
▲ Price above SMA 50 — Short-term bullish
SMA 200
326
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
31K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Fermenta Biotech Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Fermenta Biotech Ltd (FERMENTA) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Fermenta Biotech Ltd

About FERMENTA (Fermenta Biotech Ltd)

Fermenta Biotech Ltd is a dynamic pharmaceutical company carving a niche for itself in the global landscape. Beyond its core function of manufacturing, Fermenta Biotech actively cu...ltivates innovative solutions for a healthier future. It's not just about churning out drugs, but about strategically developing and marketing a diverse portfolio of chemical compounds, high-quality bulk drug substances, and specialized enzymes, all meticulously crafted to meet stringent international standards. This dedication extends beyond human health, encompassing environmental solutions designed to promote sustainability and responsible practices within the industry. With a commitment to research and development, Fermenta is continuously exploring new frontiers in biotechnology, aiming to deliver impactful products that improve quality of life. Fermenta Biotech’s influence expands beyond the laboratory, reaching into the realms of health and wellness through education and community engagement. Recognizing the importance of preventative care, the company actively supports initiatives aimed at raising health awareness and promoting healthy lifestyles. This holistic approach reflects a dedication to improving the well-being of individuals and communities. Furthermore, Fermenta Biotech showcases a smart business acumen by strategically managing property assets, indicating a financially sound approach to long-term sustainability and growth. This blend of scientific innovation, responsible environmental practices, and shrewd business decisions positions Fermenta as a forward-thinking player in the pharmaceutical sector. Central to Fermenta Biotech's product offerings is a diverse range of Vitamin D3 variants, carefully formulated to address the specific needs of various industries. From crystalline oil for pharmaceutical applications to feed-grade powder for animal nutrition, the company leverages its expertise in biotechnology to deliver tailored solutions. These products are rigorously tested and manufactured under strict quality control measures, ensuring efficacy and safety for consumers. The company's continuous investment in research and development reflects its commitment to staying at the forefront of innovation and providing high-quality products that contribute to improved health outcomes and nutritional well-being across diverse sectors.

Company Details

Symbol:FERMENTA
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Prashant Prabhakar Nagre
MD & Additional Director
Mr. Krishna Vasantkumar Datla
Executive Vice-Chairman
Mr. Sumesh Gandhi CA
Group CFO & President

FERMENTA Share Price: Frequently Asked Questions

What is the current share price of Fermenta Biotech Ltd?

Fermenta Biotech Ltd (FERMENTA) trades at ₹559.55 on NSE and BSE. Market cap ₹1.34K (Cr). Educational data only.

What is the P/E ratio of Fermenta Biotech Ltd?

Fermenta Biotech Ltd has a P/E of 20.04x vs industry average 34.89x.

What is the Bull Run score for Fermenta Biotech Ltd?

Fermenta Biotech Ltd has a Bull Run score of 44/100 based on 25+ financial parameters.

Does Fermenta Biotech Ltd pay dividends?

Fermenta Biotech Ltd has a dividend yield of 0.82%. Past dividends don't guarantee future payments.

What is the ROE of Fermenta Biotech Ltd?

Fermenta Biotech Ltd has ROE of 17.36%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Fermenta Biotech Ltd?

Fermenta Biotech Ltd has debt-to-equity of 0.28.

Is Fermenta Biotech Ltd a good investment?

Bull Run gives Fermenta Biotech Ltd a score of 44/100. This is not investment advice — consult a SEBI-registered advisor.